drugset / Trial / NCT06352424
A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity
RandomizedCrossoverSingle-blindTreatment
Summary
The main objective of this trial is to investigate the effect of BI 1820237 alone, BI 456906 alone, combination of BI 1820237 and BI 456906 versus placebo on brain activity.
Timeline
- Start
- 2024-04-30
- Primary completion
- 2025-02-24
- Completion
- 2025-02-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1820237 | Unknown | — | Subcutaneous |
| Subject | Survodutide | Protein / enzyme biologic | — | Subcutaneous |